![Brook Riggins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brook Riggins
Finansdirektör/CFO på
THIOGENESIS THERAPEUTICS, CORP.
Förmögenhet: 441 000 $ per 2026-07-31
Profil
Brook G.
Riggins is Chief Financial Officer & Director at Thiogenesis Therapeutics, Inc. Mr. Riggins is Chief Financial Officer, Secretary & Director at Thiogenesis Therapeutics Corp.
since 2018.
Mr. Riggins is Principal at Beruscha Capital Sro since 2010.
Former roles include Director at Pulse Capital Corp.
in 2011, Director at Aurora Solar Technologies, Inc. from 2011 to 2012, Director, Chief Executive & Financial Officer at Rozdil Capital Corp., Vice President at Canaccord Adams Ltd., Chief Investment Officer at Limetree Capital AG from 2008 to 2010, and Vice President-Finance at Genetronics Biomedical Corp.
from 2002 to 2004.
Education includes undergraduate studies at the University of British Columbia and an MBA from The Schulich School of Business.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-07-28 | 1 050 000 ( 1,5 % ) | 441 000 $ | 2026-07-31 |
Aktiva positioner av Brook Riggins
| Företag | Position | Start |
|---|---|---|
| THIOGENESIS THERAPEUTICS, CORP. | Finansdirektör/CFO | 2018-05-03 |
Beruscha Capital Sro | Företagsledare/Principal | 2010-12-01 |
Tidigare kända positioner av Brook Riggins
| Företag | Position | Slut |
|---|---|---|
| AURORA SOLAR TECHNOLOGIES INC. | Direktör/Styrelseledamot | 2012-03-01 |
Pulse Capital Corp.
 Pulse Capital Corp. Financial ConglomeratesFinance Capital Pool Company | Direktör/Styrelseledamot | 2011-12-08 |
Limetree Capital AG | Chef för investeringar | 2010-07-01 |
Genetronics Biomedical Corp.
 Genetronics Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Specializes in targeted intracellular delivery of therapeutic molecules | Finansdirektör/CFO | 2004-01-01 |
Canaccord Adams Ltd.
 Canaccord Adams Ltd. Investment Banks/BrokersFinance Provides corporate finance, investment advice and brokerage services | Företagsledare/Principal | - |
Brook Rigginss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
14
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
Genetronics Biomedical Corp.
Genetronics Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Specializes in targeted intracellular delivery of therapeutic molecules | Commercial Services |
Pulse Capital Corp.
Pulse Capital Corp. Financial ConglomeratesFinance Capital Pool Company | Finance |
Canaccord Adams Ltd.
Canaccord Adams Ltd. Investment Banks/BrokersFinance Provides corporate finance, investment advice and brokerage services | Finance |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Limetree Capital AG | |
Aurora Solar Technologies, Inc.
 Aurora Solar Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops and markets quality control systems for the solar cell manufacturing industry | Electronic Technology |
The Schulich School of Business
 The Schulich School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rozdil Capital Corp.
 Rozdil Capital Corp. Financial ConglomeratesFinance Operates as capital pool company | Finance |
Beruscha Capital Sro | |
Thiogenesis Therapeutics Corp.
 Thiogenesis Therapeutics Corp. Financial ConglomeratesFinance Processes drugs in pharmaceutical preparations | Finance |
